PubMed:18031991
Annnotations
sonoma2
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T0 | 48-51 | GENE | denotes | RGS |
T1 | 70-86 | POSREG | denotes | gain-of-function |
T2 | 97-129 | GENE | denotes | Regulator of G protein signaling |
T3 | 131-134 | GENE | denotes | RGS |
T4 | 269-280 | VAR | denotes | Alterations |
T5 | 284-287 | GENE | denotes | RGS |
T6 | 307-317 | REG | denotes | implicated |
T7 | 337-344 | DISEASE | denotes | disease |
T8 | 517-520 | GENE | denotes | RGS |
T9 | 577-580 | GENE | denotes | RGS |
T10 | 662-666 | GENE | denotes | RGS4 |
T11 | 689-697 | POSREG | denotes | enhanced |
T12 | 734-743 | VAR | denotes | RGS4(S30C |
T13 | 734-743 | GENE | denotes | RGS4(S30C |
T14 | 758-761 | POSREG | denotes | GOF |
T15 | 846-855 | GENE | denotes | Galpha(o1 |
T16 | 865-874 | REG | denotes | contained |
T17 | 1008-1021 | VAR | denotes | substitutions |
T18 | 1037-1040 | POSREG | denotes | GOF |
T19 | 1041-1049 | MPA | denotes | activity |
T20 | 1068-1076 | POSREG | denotes | retained |
T21 | 1122-1130 | VAR | denotes | mutation |
T22 | 1173-1178 | GENE | denotes | RGS16 |
T23 | 1210-1213 | POSREG | denotes | GOF |
T24 | 1214-1221 | VAR | denotes | mutants |
T25 | 1223-1241 | GENE | denotes | RGS4(S30C/S30F/S30 |
T26 | 1266-1293 | MPA | denotes | steady state protein levels |
T27 | 1309-1316 | VAR | denotes | mutants |
T28 | 1334-1342 | POSREG | denotes | enhanced |
T29 | 1343-1355 | MPA | denotes | GAP activity |
T30 | 1416-1431 | MPA | denotes | protein content |
T31 | 1461-1464 | GENE | denotes | RGS |
T32 | 1465-1472 | VAR | denotes | mutants |
T33 | 1478-1481 | POSREG | denotes | GOF |
T34 | 1609-1618 | VAR | denotes | mutations |
T35 | 1634-1637 | GENE | denotes | RGS |
R0 | T4 | T6 | CauseOf | Alterations,implicated |
R1 | T7 | T6 | ThemeOf | disease,implicated |
R2 | T12 | T14 | CauseOf | RGS4(S30C,GOF |
R3 | T15 | T16 | ThemeOf | Galpha(o1,contained |
R4 | T17 | T18 | CauseOf | substitutions,GOF |
R5 | T19 | T18 | ThemeOf | activity,GOF |
R6 | T21 | T20 | CauseOf | mutation,retained |
R7 | T22 | T21 | ThemeOf | RGS16,mutation |
R8 | T24 | T23 | CauseOf | mutants,GOF |
R9 | T24 | T28 | CauseOf | mutants,enhanced |
R10 | T27 | T23 | CauseOf | mutants,GOF |
R11 | T27 | T28 | CauseOf | mutants,enhanced |
R12 | T29 | T28 | ThemeOf | GAP activity,enhanced |
R13 | T31 | T32 | ThemeOf | RGS,mutants |
R14 | T31 | T34 | ThemeOf | RGS,mutations |
R15 | T32 | T33 | CauseOf | mutants,GOF |
R16 | T34 | T33 | CauseOf | mutations,GOF |
kaiyin_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 195-206 | PosReg | denotes | stimulation |
T3 | 210-237 | Protein | denotes | G protein-coupled receptors |
T4 | 242-267 | Protein | denotes | heterotrimeric G proteins |
T9 | 269-280 | Var | denotes | Alterations |
T26 | 284-287 | Protein | denotes | RGS |
T8 | 307-317 | Reg | denotes | implicated |
T5 | 337-344 | Disease | denotes | disease |
T30 | 480-488 | NegReg | denotes | reducing |
T31 | 492-502 | NegReg | denotes | inhibiting |
T11 | 517-529 | Protein | denotes | RGS proteins |
T12 | 662-673 | Var | denotes | RGS4 mutant |
T13 | 689-697 | PosReg | denotes | enhanced |
T25 | 701-717 | PosReg | denotes | gain-of-function |
T14 | 790-820 | Pathway | denotes | yeast-based signalling pathway |
T15 | 846-938 | Protein | denotes | Galpha(o1) subunit contained in an alpha(2A)-adrenoreceptor-Galpha(o1)(C351I) fusion protein |
T19 | 1223-1227 | Var | denotes | RGS4 |
T27 | 1228-1232 | Var | denotes | S30C |
T28 | 1233-1237 | Var | denotes | S30F |
T29 | 1238-1242 | Var | denotes | S30K |
T20 | 1256-1265 | PosReg | denotes | increased |
T21 | 1279-1293 | MPA | denotes | protein levels |
T23 | 1334-1342 | PosReg | denotes | enhanced |
T24 | 1343-1355 | MPA | denotes | GAP activity |
R1 | T4 | T1 | CauseOf | heterotrimeric G proteins,stimulation |
R11 | T19 | T20 | CauseOf | RGS4,increased |
R12 | T21 | T20 | ThemeOf | protein levels,increased |
R14 | T24 | T23 | ThemeOf | GAP activity,enhanced |
R15 | T12 | T25 | CauseOf | RGS4 mutant,gain-of-function |
R16 | T14 | T25 | ThemeOf | yeast-based signalling pathway,gain-of-function |
R17 | T15 | T25 | ThemeOf | Galpha(o1) subunit contained in an alpha(2A)-adrenoreceptor-Galpha(o1)(C351I) fusion protein,gain-of-function |
R18 | T26 | T9 | ThemeOf | RGS,Alterations |
R19 | T19 | T23 | CauseOf | RGS4,enhanced |
R2 | T3 | T1 | ThemeOf | G protein-coupled receptors,stimulation |
R20 | T27 | T19 | ThemeOf | S30C,RGS4 |
R21 | T28 | T19 | ThemeOf | S30F,RGS4 |
R22 | T29 | T19 | ThemeOf | S30K,RGS4 |
R23 | T11 | T30 | ThemeOf | RGS proteins,reducing |
R24 | T11 | T31 | ThemeOf | RGS proteins,inhibiting |
R3 | T9 | T8 | CauseOf | Alterations,implicated |
R4 | T5 | T8 | ThemeOf | disease,implicated |
R6 | T12 | T13 | CauseOf | RGS4 mutant,enhanced |
R7 | T14 | T13 | ThemeOf | yeast-based signalling pathway,enhanced |
R8 | T15 | T13 | ThemeOf | Galpha(o1) subunit contained in an alpha(2A)-adrenoreceptor-Galpha(o1)(C351I) fusion protein,enhanced |
name_no
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 195-206 | PosReg | denotes | stimulation |
T3 | 210-237 | Protein | denotes | G protein-coupled receptors |
T4 | 242-267 | Protein | denotes | heterotrimeric G proteins |
T9 | 269-280 | Var | denotes | Alterations |
T26 | 284-287 | Protein | denotes | RGS |
T8 | 307-317 | Reg | denotes | implicated |
T5 | 337-344 | Disease | denotes | disease |
T30 | 480-488 | NegReg | denotes | reducing |
T31 | 492-502 | NegReg | denotes | inhibiting |
T11 | 517-529 | Protein | denotes | RGS proteins |
T12 | 662-673 | Var | denotes | RGS4 mutant |
T13 | 689-697 | PosReg | denotes | enhanced |
T25 | 701-717 | PosReg | denotes | gain-of-function |
T14 | 790-820 | Pathway | denotes | yeast-based signalling pathway |
T15 | 846-938 | Protein | denotes | Galpha(o1) subunit contained in an alpha(2A)-adrenoreceptor-Galpha(o1)(C351I) fusion protein |
T19 | 1223-1227 | Var | denotes | RGS4 |
T27 | 1228-1232 | Var | denotes | S30C |
T28 | 1233-1237 | Var | denotes | S30F |
T29 | 1238-1242 | Var | denotes | S30K |
T20 | 1256-1265 | PosReg | denotes | increased |
T21 | 1279-1293 | MPA | denotes | protein levels |
T23 | 1334-1342 | PosReg | denotes | enhanced |
T24 | 1343-1355 | MPA | denotes | GAP activity |
R1 | T4 | T1 | CauseOf | heterotrimeric G proteins,stimulation |
R11 | T19 | T20 | CauseOf | RGS4,increased |
R12 | T21 | T20 | ThemeOf | protein levels,increased |
R14 | T24 | T23 | ThemeOf | GAP activity,enhanced |
R15 | T12 | T25 | CauseOf | RGS4 mutant,gain-of-function |
R16 | T14 | T25 | ThemeOf | yeast-based signalling pathway,gain-of-function |
R17 | T15 | T25 | ThemeOf | Galpha(o1) subunit contained in an alpha(2A)-adrenoreceptor-Galpha(o1)(C351I) fusion protein,gain-of-function |
R18 | T26 | T9 | ThemeOf | RGS,Alterations |
R19 | T19 | T23 | CauseOf | RGS4,enhanced |
R2 | T3 | T1 | ThemeOf | G protein-coupled receptors,stimulation |
R20 | T27 | T19 | ThemeOf | S30C,RGS4 |
R21 | T28 | T19 | ThemeOf | S30F,RGS4 |
R22 | T29 | T19 | ThemeOf | S30K,RGS4 |
R23 | T11 | T30 | ThemeOf | RGS proteins,reducing |
R24 | T11 | T31 | ThemeOf | RGS proteins,inhibiting |
R3 | T9 | T8 | CauseOf | Alterations,implicated |
R4 | T5 | T8 | ThemeOf | disease,implicated |
R6 | T12 | T13 | CauseOf | RGS4 mutant,enhanced |
R7 | T14 | T13 | ThemeOf | yeast-based signalling pathway,enhanced |
R8 | T15 | T13 | ThemeOf | Galpha(o1) subunit contained in an alpha(2A)-adrenoreceptor-Galpha(o1)(C351I) fusion protein,enhanced |